Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19

2 years ago

U.S. Army-Funded Project Will Support Further Development of Novel Therapeutic ModalityDURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma, a clinical-stage company advancing a proprietary…

Justera Completes Acquisition of K-Beauty Company, Triniti Trading Corp.

2 years ago

Toronto, Ontario--(Newsfile Corp. - November 15, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")…

LeAnn Boyd Wins Stevie Award for Women in Business

2 years ago

International event in NYC recognizes 2023 Stevie Award recipients.Natchitoches, Louisiana--(Newsfile Corp. - November 15, 2023) - LeAnn Boyd, Liviniti CEO,…

FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023

2 years ago

TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

Halberd Corporation Plans to Extend Research Partnership with Mississippi State University

2 years ago

MSU Research for Halberd to Transcend the TBI Nasal SprayJACKSON CENTER, PA / ACCESSWIRE / November 15, 2023 / Halberd…

City Trees Announces New Market Venture in New Mexico Through Licensing Agreement.

2 years ago

LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a…

CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End

2 years ago

- Enrollment numbers rise to 239 in ongoing potentially pivotal study of Berubicin for treatment of GBM; Expected full enrollment…

StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update

2 years ago

TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare…

Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman

2 years ago

The new board and leadership appointment aligns with the company's commitment to advancing the industry through innovation and the expansion…

NanoViricides Has Filed its Quarterly Report – NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications

2 years ago

SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed…